ACUMEN Diagnostics, a subsidiary of mainboard-listed Q&M Dental Group, is exploring a proposed listing on the Nasdaq stock exchange in New York, Q&M said on Monday (Jan 17).

THE following companies saw new developments that may affect trading of their securities on Monday (Jan 17):

In its 2022 outlook strategy report dated Jan 6, PhillipCapital’s head of research Paul Chew has listed four themes he expects to see during the year. These are: inflation peaking and the easing of supply chain constraints; vaccines to bend mortality [rates]; modestly higher interest rates and a r...

ACUMEN Diagnostics, which is 51:49 owned by Q&M Dental Group and Aoxin Q&M Dental Group, on Thursday (Dec 16) announced that it has been granted a licence by the Ministry of Health to provide swabbing and Covid-19 polymerase chain reaction (PCR) tests services.

Acumen Diagnostics, a 51%-owned subsidiary of Q&M Dental Group and 49%-owned by Aoxin Q&M Dental Group, says it has been granted a license by the Ministry of Health (MOH) to provide offsite Covid-19 polymerase chain reaction (PCR) swab services and serology sample collection. Acumen Diagnost...

Analysts are maintaining bullish end-2022 targets, even as the Omicron variant is the latest hurdle to the market’s eventful recovery journey. Meanwhile, will the much-heralded Spac framework carry the IPO momentum forward? Singapore may have seen multiple months of lockdowns and fewer IPOs in 202...

CATALIST-LISTED Aoxin Q & M Dental Group said on Monday (Dec 6) that it has reopened 4 of its dental centres in the Chinese province of Liaoning.

Aura Private Equity – a division under Singapore-headquartered fund manager Aura Group – is set to acquire a majority stake in Australian Vaccine Services (AVS). While the transaction amount has not been disclosed, Aura Private Equity is typically seen writing cheques of around US$10 million ($1...

Acumen Diagnostics, the 51%-owned subsidiary of Q&M Dental Group and 49%-owned by Aoxin Q&M Dental, says its proprietary, locally-manufactured polymerase chain reaction (PCR) test kits are able to detect Covid-19 positive cases with the Omicron variant. The kits are named Acu-Corona 2.0 and ...

Nikhil Eapen, StarHub’s CEO, on Nov 25 acquired 730,000 shares for over $1 million or $1.377904 each on the open market. Before this transaction, Eapen, who began this role in January, did not own any StarHub shares. He was previously deputy CEO of ST Telemedia and prior to that, a long-time inves...